SG Americas Securities
ALXO icon

SG Americas Securities’s ALX Oncology ALXO Stock Holding History

SG Americas Securities’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-22,277
Closed -$14K – 2908
2025
Q1 		$14K Sell
22,277
-1,979
-8% -$2.38K ﹤0.01% 3398
2024
Q4 		$41K Sell
24,256
-3,138
-11% -$4.82K ﹤0.01% 2939
2024
Q3 		$50K Buy
27,394
+6,888
+34% +$25.6K ﹤0.01% 3246
2024
Q2 		$124K Sell
20,506
-3,400
-14% -$41.8K ﹤0.01% 2422
2024
Q1 		$267K Sell
23,906
-6,442
-21% -$90.5K ﹤0.01% 1760
2023
Q4 		$452K Buy
30,348
+20,279
+201% +$192K ﹤0.01% 1548
2023
Q3 		$48K Buy
+10,069
New +$54.6K ﹤0.01% 2947
2022
Q4 		– Sell
-50,536
Closed -$484K – 3043
2022
Q3 		$484K Buy
50,536
+1,815
+4% +$21.2K 0.01% 1579
2022
Q2 		$394K Buy
48,721
+13,595
+39% +$148K ﹤0.01% 2161
2022
Q1 		$594K Buy
35,126
+683
+2% +$11.7K ﹤0.01% 1774
2021
Q4 		$740K Buy
34,443
+24,445
+244% +$1.05M ﹤0.01% 1862
2021
Q3 		$738K Buy
9,998
+8,103
+428% +$540K ﹤0.01% 2172
2021
Q2 		$104K Sell
1,895
-1,361
-42% -$81.4K ﹤0.01% 2652
2021
Q1 		$240K Buy
+3,256
New +$256K ﹤0.01% 2548

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

SG Americas Securities's ALXO Position: Q2 2025 in Review

SG Americas Securities sold out of ALX Oncology (ALXO) in Q2 2025, closing a stake of 22,277 shares — an estimated $14K sold.

SG Americas Securities first reported a position in ALXO in Q1 2021 and held it in 14 quarters. The position peaked at $740K in Q4 2021. 61 funds tracked by Wall St. Rank hold ALXO as of Q2 2025.

  • SG Americas Securities reported no remaining ALX Oncology position as of Q2 2025 after selling out during the quarter.
  • SG Americas Securities sold 22,277 ALX Oncology shares in Q2 2025, an estimated $14K.
  • SG Americas Securities first reported a position in ALX Oncology in Q1 2021 and held it in 14 quarters.
  • SG Americas Securities's ALX Oncology position peaked at $740K in Q4 2021.
  • 61 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2025.

Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.